India Specialty Chemicals Stocks 2025 — China+1 Export Theme NSE/BSE
India's specialty chemicals sector is the biggest beneficiary of the China+1 de-risking trend. Global buyers diversifying away from China for agrochemicals, pharma intermediates, and performance chemicals. India's specialty chemical exports are expected to reach $45B by 2030. Top stocks include PI Industries, SRF, and Aarti Industries, with EBITDA margins of 18-25% — a premium to bulk chemicals.
Stocks in this theme · India specialty chemicals
12 companies in this theme — showing top 12 by market cap.
| Symbol | Company | Price | Mkt Cap | ROE | P/E |
|---|---|---|---|---|---|
| SOLARINDS | Solar Industries India | ₹18,827.75 | ₹1,70,357 Cr | — | — |
| PIDILITIND | Pidilite Industries | ₹1,608.7 | ₹1,63,730 Cr | — | — |
| SRF | SRF | ₹2,873.1 | ₹85,081 Cr | — | — |
| COROMANDEL | Coromandel International | ₹2,035.95 | ₹60,057 Cr | — | — |
| FLUOROCHEM | Gujarat Fluorochemicals | ₹4,590.65 | ₹50,707 Cr | — | — |
| PIIND | PI Industries | ₹2,698.5 | ₹40,935 Cr | — | — |
| NAVINFLUOR | Navin Fluorine International | ₹7,787.9 | ₹39,903 Cr | — | — |
| DEEPAKNTR | Deepak Nitrite | ₹1,693.15 | ₹23,134 Cr | — | — |
| ATUL | Atul | ₹6,139.75 | ₹18,106 Cr | — | — |
| AARTIIND | Aarti Industries | ₹495.2 | ₹17,951 Cr | — | — |
| TATACHEM | Tata Chemicals | ₹691.4 | ₹17,613 Cr | — | — |
| VINATIORGA | Vinati Organics | ₹1,312.85 | ₹13,599 Cr | — | — |
Research Coverage
- Specialty Chem Stock Screener
- China vs India Chemical Export Comparison
- Contract Manufacturing Order Wins
- PI Industries CSM Business
- SniperIQ Signal on Chem Picks
- Agrochemical vs Pharma Chem Mix
Parent Discover Hub
Discover Structural Investment Themes keeps this page inside the main discover cluster with sibling theme and workflow links.
Frequently Asked Questions
What is the China+1 opportunity for Indian chemicals?
China produces 40%+ of global specialty chemicals. Post-COVID supply disruptions and US-China trade tensions pushed global buyers to develop India, Korea, and Europe as alternative sources. India's cost advantage, chemistry talent, and regulatory credibility make it the primary China+1 destination for complex molecules.